155 related articles for article (PubMed ID: 12638729)
21. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
Li R; Lindholm K; Yang LB; Yue X; Citron M; Yan R; Beach T; Sue L; Sabbagh M; Cai H; Wong P; Price D; Shen Y
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3632-7. PubMed ID: 14978286
[TBL] [Abstract][Full Text] [Related]
22. Profiles of β-Amyloid Peptides and Key Secretases in Brain Autopsy Samples Differ with Sex and APOE ε4 Status: Impact for Risk and Progression of Alzheimer Disease.
Nyarko JNK; Quartey MO; Pennington PR; Heistad RM; Dea D; Poirier J; Baker GB; Mousseau DD
Neuroscience; 2018 Mar; 373():20-36. PubMed ID: 29331531
[TBL] [Abstract][Full Text] [Related]
23. Simultaneous determination of post-translational racemization and isomerization of N-terminal amyloid-β in Alzheimer's brain tissues by covalent chiral derivatized ultraperformance liquid chromatography tandem mass spectrometry.
Inoue K; Hosaka D; Mochizuki N; Akatsu H; Tsutsumiuchi K; Hashizume Y; Matsukawa N; Yamamoto T; Toyo'oka T
Anal Chem; 2014 Jan; 86(1):797-804. PubMed ID: 24283798
[TBL] [Abstract][Full Text] [Related]
24. Plant-based chimeric HPV-virus-like particles bearing amyloid-β epitopes elicit antibodies able to recognize amyloid plaques in APP-tg mouse and Alzheimer's disease brains.
Gonzalez-Castro R; Acero Galindo G; García Salcedo Y; Uribe Campero L; Vazquez Perez V; Carrillo-Tripp M; Gevorkian G; Gomez Lim MA
Inflammopharmacology; 2018 Jun; 26(3):817-827. PubMed ID: 29094307
[TBL] [Abstract][Full Text] [Related]
25. Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry.
Portelius E; Lashley T; Westerlund A; Persson R; Fox NC; Blennow K; Revesz T; Zetterberg H
Neurodegener Dis; 2015; 15(1):50-7. PubMed ID: 25591542
[TBL] [Abstract][Full Text] [Related]
26. Novel Phosphorylation-State Specific Antibodies Reveal Differential Deposition of Ser26 Phosphorylated Aβ Species in a Mouse Model of Alzheimer's Disease.
Kumar S; Kapadia A; Theil S; Joshi P; Riffel F; Heneka MT; Walter J
Front Mol Neurosci; 2020; 13():619639. PubMed ID: 33519377
[TBL] [Abstract][Full Text] [Related]
27. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
[TBL] [Abstract][Full Text] [Related]
28. [Expression of apolipoprotein E in Alzheimer's disease and its significance].
He SR; Liu DG; Wang S; Xia YJ
Zhonghua Bing Li Xue Za Zhi; 2005 Sep; 34(9):556-60. PubMed ID: 16468304
[TBL] [Abstract][Full Text] [Related]
29. N-truncated Aβ
Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
[TBL] [Abstract][Full Text] [Related]
30. [Alzheimer disease: cellular and molecular aspects].
Octave JN
Bull Mem Acad R Med Belg; 2005; 160(10-12):445-9; discussion 450-1. PubMed ID: 16768248
[TBL] [Abstract][Full Text] [Related]
31. Suppression of mitochondrial succinate dehydrogenase, a primary target of beta-amyloid, and its derivative racemized at Ser residue.
Kaneko I; Yamada N; Sakuraba Y; Kamenosono M; Tutumi S
J Neurochem; 1995 Dec; 65(6):2585-93. PubMed ID: 7595555
[TBL] [Abstract][Full Text] [Related]
32. The levels of soluble versus insoluble brain Abeta distinguish Alzheimer's disease from normal and pathologic aging.
Wang J; Dickson DW; Trojanowski JQ; Lee VM
Exp Neurol; 1999 Aug; 158(2):328-37. PubMed ID: 10415140
[TBL] [Abstract][Full Text] [Related]
33. Isoaspartate formation and neurodegeneration in Alzheimer's disease.
Shimizu T; Watanabe A; Ogawara M; Mori H; Shirasawa T
Arch Biochem Biophys; 2000 Sep; 381(2):225-34. PubMed ID: 11032409
[TBL] [Abstract][Full Text] [Related]
34. Role of hippocalcin in mediating Aβ toxicity.
Lim YA; Giese M; Shepherd C; Halliday G; Kobayashi M; Takamatsu K; Staufenbiel M; Eckert A; Götz J
Biochim Biophys Acta; 2012 Aug; 1822(8):1247-57. PubMed ID: 22542901
[TBL] [Abstract][Full Text] [Related]
35. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels.
Schedin-Weiss S; Inoue M; Hromadkova L; Teranishi Y; Yamamoto NG; Wiehager B; Bogdanovic N; Winblad B; Sandebring-Matton A; Frykman S; Tjernberg LO
Alzheimers Res Ther; 2017 Aug; 9(1):57. PubMed ID: 28764767
[TBL] [Abstract][Full Text] [Related]
36. Antibody 9D5 recognizes oligomeric pyroglutamate amyloid-β in a fraction of amyloid-β deposits in Alzheimer's disease without cross-reactivity with other protein aggregates.
Venkataramani V; Wirths O; Budka H; Härtig W; Kovacs GG; Bayer TA
J Alzheimers Dis; 2012; 29(2):361-71. PubMed ID: 22232007
[TBL] [Abstract][Full Text] [Related]
37. Microglia contributes to plaque growth by cell death due to uptake of amyloid β in the brain of Alzheimer's disease mouse model.
Baik SH; Kang S; Son SM; Mook-Jung I
Glia; 2016 Dec; 64(12):2274-2290. PubMed ID: 27658617
[TBL] [Abstract][Full Text] [Related]
38. Amyloid-β and tau: the trigger and bullet in Alzheimer disease pathogenesis.
Bloom GS
JAMA Neurol; 2014 Apr; 71(4):505-8. PubMed ID: 24493463
[TBL] [Abstract][Full Text] [Related]
39. Extracellular neurofibrillary tangles are immunopositive for the 40 carboxy-terminal sequence of beta-amyloid protein.
Schwab C; Akiyama H; McGeer EG; McGeer PL
J Neuropathol Exp Neurol; 1998 Dec; 57(12):1131-7. PubMed ID: 9862635
[TBL] [Abstract][Full Text] [Related]
40. Aberrant proteolytic processing and therapeutic strategies in Alzheimer disease.
Tomita T
Adv Biol Regul; 2017 May; 64():33-38. PubMed ID: 28082052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
